do-me/EUR-LEX huggingface dataset:
Case T-429/24: Action brought on 15 August 2024 – Paul Hartmann v EUIPO – Medisept (MEDISET)
Date: 2024-08-15
Institutions: General Court
Subjects: EU trade mark, medical device, registered trade mark, trade-mark law








C_202405655EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/5655


30.9.2024






Action brought on 15 August 2024 – Paul Hartmann v EUIPO – Medisept (MEDISET)


(Case T-429/24)

(C/2024/5655)
Language in which the application was lodged: French

Parties


Applicant: Paul Hartmann AG (Heidenheim, Germany) (represented by: L. Rothmund-Feise, lawyer)

Defendant: European Union Intellectual Property Office

Other party to the proceedings before the Board of Appeal: Medisept sp. z.o.o. (Lublin, Poland)

Details of the proceedings before EUIPO


Proprietor of the trade mark at issue: Applicant

Trade mark at issue: International registration designating the European Union in respect of the mark MEDISET – International registration designating the European Union No 10 626 566
         

Proceedings before EUIPO: Invalidity proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 18 June 2024 in Case R 235/2023-2

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision in so far as it rejects the appeal;










—


reject the application for a declaration of invalidity of the mark at issue;










—


order EUIPO to pay the costs.





Pleas in law

Infringement of Article 7(1)(c) and (2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;
Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.


ELI: http://data.europa.eu/eli/C/2024/5655/oj
ISSN 1977-091X (electronic edition)